CRISPR And CRISPR-associated (Cas) Genes Market Share

Statistics for the 2023 & 2024 CRISPR And CRISPR-associated (Cas) Genes market share, created by Mordor Intelligence™ Industry Reports. CRISPR And CRISPR-associated (Cas) Genes share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of CRISPR And CRISPR-associated (Cas) Genes Industry

The CRISPR and CRISPR-associated (Cas) genes market is consolidated and consists of a few major players. Additionally, the key players have been involved in various strategic alliances, such as acquisitions, collaborations, and financing, along with the launch of advanced products to secure their position in the global market. Some of the key market players are OriGene Technologies, Inc., Thermo Fisher Scientific, Takara Bio Inc, PerkinElmer Inc. (Horizon Discovery Ltd.), Addgene, Merck KGaA, Caribou Biosciences, Inc., CRISPR THERAPEUTICS, Editas Medicine, and Mirus Bio LLC.

CRISPR and CAS Genes Market Leaders

  1. OriGene Technologies, Inc.

  2. Thermo Fisher Scientific

  3. Takara Bio Inc

  4. Addgene

  5. PerkinElmer Inc. (Horizon Discovery Ltd.)

*Disclaimer: Major Players sorted in no particular order

CRISPR And CRISPR-associated (Cas) Genes Market Concentration

CRISPR & CAS Genes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)